首页 > 最新文献

Recent patents on biotechnology最新文献

英文 中文
Phytochemical Analysis and Antimicrobial Potential of Parthenium hysterophorous and Lantana camara. 紫茎蕨(Parthenium hysterophorous)和香茶菜(Lantana camara)的植物化学分析和抗菌潜力。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-08-27 DOI: 10.2174/0118722083316748240821151703
Aliya Firdaus, Syed Khalida Izhar, Shazia Qamar, Arshi Siddiqui, Uzma Afaq

Background: Parthenium hysterophorous and Lantana camara are notable for their significant phytochemical and antimicrobial properties. Advancements in phytochemical research have led to the development of novel formulations and products derived from P. hysterophorus and L. camara. For instance, patent extracts from these plants have been utilized in the formulation of pharmaceutical drugs, herbal supplements, cosmeceuticals, and agricultural products. P. hysterophorous, commonly known as Santa Maria feverfew or Congress grass, contains various bioactive compounds like terpenoids, flavonoids, phenolics, and alkaloids.These compounds are the key to its medicinal properties, particularly its antimicrobial activity. On the other hand, L. camara, often referred to as wild sage, is rich in phytochemicals such as terpenoids, flavonoids, and alkaloid glycosides.

Methods: P. hysterophorous and L. camara plants selected and checking their antimicrobial activity by agar well diffusion method.

Results: In our study, we found that the leaf extract of P. hysterophorous exhibited the most potent antibacterial activity against E. coli. P. hysterophorous exhibited the most potent antifungal activity against A. niger and T. viride, with a diameter of inhibition zone measuring 12 mm, followed by A. flavus and A. parasiticus. In case of L. camara, the inhibitory zone ranging from 14 to 18 mm was detected against S. abony, P. aeruginosa, E. coli, and K. pneumonia. The leaf extract of the maximum zone of inhibition in case of L. camara was shown by A. flavus (12mm).

Conclusion: The present study suggests that these two weeds could be useful in the development of bactericides and fungicides.

背景:石蒜(Parthenium hysterophorous)和香茶菜(Lantana camara)具有显著的植物化学和抗菌特性。随着植物化学研究的不断进步,人们开发出了从紫花地丁(P. hysterophorus)和香蒲(L. camara)中提取的新型配方和产品。例如,这些植物的专利提取物已被用于配制药物、草药补充剂、药用化妆品和农产品。P. hysterophorous,俗称圣玛丽亚发热草或国会草,含有多种生物活性化合物,如萜类、黄酮类、酚类和生物碱。另一方面,常被称为野生鼠尾草的 L. camara 含有丰富的植物化学物质,如萜类、黄酮类和生物碱苷类:方法:选择 P. hysterophorous 和 L. camara 植物,用琼脂井扩散法检测其抗菌活性:结果:在研究中,我们发现紫菀的叶提取物对大肠杆菌具有最强的抗菌活性。紫檀叶提取物对黑曲霉和白曲霉的抗真菌活性最强,抑制区直径达 12 毫米,其次是黄曲霉和寄生菌。L. camara 对 S. abony、P. aeruginosa、E. coli 和 K. pneumonia 的抑制区为 14 至 18 毫米。结论:本研究表明,这两种杂草可用于开发杀菌剂和杀真菌剂。
{"title":"Phytochemical Analysis and Antimicrobial Potential of Parthenium hysterophorous and Lantana camara.","authors":"Aliya Firdaus, Syed Khalida Izhar, Shazia Qamar, Arshi Siddiqui, Uzma Afaq","doi":"10.2174/0118722083316748240821151703","DOIUrl":"https://doi.org/10.2174/0118722083316748240821151703","url":null,"abstract":"<p><strong>Background: </strong>Parthenium hysterophorous and Lantana camara are notable for their significant phytochemical and antimicrobial properties. Advancements in phytochemical research have led to the development of novel formulations and products derived from P. hysterophorus and L. camara. For instance, patent extracts from these plants have been utilized in the formulation of pharmaceutical drugs, herbal supplements, cosmeceuticals, and agricultural products. P. hysterophorous, commonly known as Santa Maria feverfew or Congress grass, contains various bioactive compounds like terpenoids, flavonoids, phenolics, and alkaloids.These compounds are the key to its medicinal properties, particularly its antimicrobial activity. On the other hand, L. camara, often referred to as wild sage, is rich in phytochemicals such as terpenoids, flavonoids, and alkaloid glycosides.</p><p><strong>Methods: </strong>P. hysterophorous and L. camara plants selected and checking their antimicrobial activity by agar well diffusion method.</p><p><strong>Results: </strong>In our study, we found that the leaf extract of P. hysterophorous exhibited the most potent antibacterial activity against E. coli. P. hysterophorous exhibited the most potent antifungal activity against A. niger and T. viride, with a diameter of inhibition zone measuring 12 mm, followed by A. flavus and A. parasiticus. In case of L. camara, the inhibitory zone ranging from 14 to 18 mm was detected against S. abony, P. aeruginosa, E. coli, and K. pneumonia. The leaf extract of the maximum zone of inhibition in case of L. camara was shown by A. flavus (12mm).</p><p><strong>Conclusion: </strong>The present study suggests that these two weeds could be useful in the development of bactericides and fungicides.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Landscape of Products for Diabetic Peripheral Neuropathy: A Scientific and Patent Systematic Review. 糖尿病周围神经病变产品的现状:科学与专利系统回顾
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-08-27 DOI: 10.2174/0118722083314714240820115610
Giselda Dos Santos Barros, Paula Dos Passos Menezes, Simone de Cássia Silva, Gabriel Francisco da Silva

Background: Diabetic peripheral neuropathy (DPN) is a complication of diabetes that occurs in 40 - 60 million individuals worldwide and is associated with other chronic diseases. However, there are no review studies that present the state-of- the- art and technologies developed to circumvent this important health problem.

Material and methods: This review was conducted based on scientific papers and patents. The papers were retrieved from Lilacs, PubMed, and Web of Science databases, and the patents from INPI, ESPACENET, WIPO, and GOOGLE PATENTS. Thus, a sample consisting of 14 scientific articles and 667 patents was analyzed.

Results: From the analysis of the data, we drew an overview of the development of biomedical technologies for DPN and detected the pioneering spirit of China, the USA, and Japan in the area, with a focus on the treatment of DPN. Based on this, we carried out a SWOT analysis to help direct future efforts in the area, which should focus primarily on developing technologies for prevention, early diagnosis, and, above all, cure of the disease to reduce the important impact of this disease in various sectors of society.

Conclusion: This study finds a concentration of diabetic peripheral neuropathy products, especially therapeutic drugs, in high-income countries. It highlights the need for global collaboration and strategic focus on therapeutic adherence and preventive strategies to effectively manage DPN.

背景:糖尿病周围神经病变(DPN)是糖尿病的一种并发症,全世界有 4,000-6,000 万糖尿病患者,并与其他慢性疾病相关。然而,目前还没有综述性研究介绍最新技术和为解决这一重要健康问题而开发的技术:本综述以科学论文和专利为基础。论文来自 Lilacs、PubMed 和 Web of Science 数据库,专利来自 INPI、ESPACENET、WIPO 和 GOOGLE PATENTS。因此,我们分析了由 14 篇科学论文和 667 项专利组成的样本:结果:通过对数据的分析,我们得出了针对 DPN 的生物医学技术的发展概况,并发现了中国、美国和日本在该领域的开拓精神,重点是 DPN 的治疗。在此基础上,我们进行了 SWOT 分析,以帮助指导该领域未来的工作,其主要重点应放在开发预防、早期诊断,尤其是治愈该疾病的技术上,以减少该疾病对社会各部门的重要影响:本研究发现,糖尿病周围神经病变产品,尤其是治疗药物,主要集中在高收入国家。它强调了全球合作的必要性,以及将战略重点放在坚持治疗和预防策略上以有效控制糖尿病周围神经病变的必要性。
{"title":"The Landscape of Products for Diabetic Peripheral Neuropathy: A Scientific and Patent Systematic Review.","authors":"Giselda Dos Santos Barros, Paula Dos Passos Menezes, Simone de Cássia Silva, Gabriel Francisco da Silva","doi":"10.2174/0118722083314714240820115610","DOIUrl":"https://doi.org/10.2174/0118722083314714240820115610","url":null,"abstract":"<p><strong>Background: </strong>Diabetic peripheral neuropathy (DPN) is a complication of diabetes that occurs in 40 - 60 million individuals worldwide and is associated with other chronic diseases. However, there are no review studies that present the state-of- the- art and technologies developed to circumvent this important health problem.</p><p><strong>Material and methods: </strong>This review was conducted based on scientific papers and patents. The papers were retrieved from Lilacs, PubMed, and Web of Science databases, and the patents from INPI, ESPACENET, WIPO, and GOOGLE PATENTS. Thus, a sample consisting of 14 scientific articles and 667 patents was analyzed.</p><p><strong>Results: </strong>From the analysis of the data, we drew an overview of the development of biomedical technologies for DPN and detected the pioneering spirit of China, the USA, and Japan in the area, with a focus on the treatment of DPN. Based on this, we carried out a SWOT analysis to help direct future efforts in the area, which should focus primarily on developing technologies for prevention, early diagnosis, and, above all, cure of the disease to reduce the important impact of this disease in various sectors of society.</p><p><strong>Conclusion: </strong>This study finds a concentration of diabetic peripheral neuropathy products, especially therapeutic drugs, in high-income countries. It highlights the need for global collaboration and strategic focus on therapeutic adherence and preventive strategies to effectively manage DPN.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Mycorrhizal Fungi in Orchids Mycobiont and Orchids. 菌根真菌在兰花中的作用 菌根和兰花。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-08-27 DOI: 10.2174/0118722083312186240822051057
Saranjeet Kaur, Akash Deb

Background: In nature, orchid plants are obligate myco-heterotrophs, and rely on mycorrhizal nutrient resources to grow and sustain in the wild, until they become physiologically active photosynthetic plants. Their seeds lack nutrient reserves and receive the necessary carbon from symbiotic fungi during germination. A mycorrhizal fungus provides nutrients, especially sugars, as well as water to the corresponding host plant. The range and distribution of orchid mycorrhizal fungi influence the survivability of orchid populations in their natural habitats. Mycorrhizae form symbiotic connections with the parenchymatous tissues of the roots of orchid plants.

Objective: The objective of this study was to examine the presence of mycorrhiza in the roots of Aerides multiflora during the vegetative phase Methods: Fresh roots were hand-sectioned, and thin sections were observed under the microscope to locate the presence of mycorrhiza. Simultaneously, to observe the expansion of mycorrhiza in the cortical region.

Results: During the vegetative phase of plant growth, a peloton-like structure forms within the cortical region of the orchid roots. Mycorrhizae was observed to be distributed throughout the cortical layer of the root.

Conclusion: This communication reviews the role of mycorrhiza in orchid plants.

背景:在自然界中,兰科植物是必须的真菌异养生物,依靠菌根营养资源在野外生长和维持,直至成为生理上活跃的光合作用植物。它们的种子缺乏营养储备,在发芽过程中会从共生真菌那里获得必要的碳。菌根真菌为相应的寄主植物提供养分(尤其是糖)和水分。兰花菌根真菌的分布范围和分布情况影响着兰花种群在自然栖息地的生存能力。菌根与兰科植物根部的实质组织形成共生连接:本研究的目的是检测多花植物根部无性期菌根的存在情况:对新鲜根系进行手工切片,在显微镜下观察薄片以确定菌根的存在。同时,观察菌根在皮层区域的扩展情况:结果:在植物生长的无性繁殖阶段,兰花根部皮层区域会形成一个球状结构。据观察,菌根分布在根的整个皮层中:这篇通讯回顾了菌根在兰科植物中的作用。
{"title":"The Role of Mycorrhizal Fungi in Orchids Mycobiont and Orchids.","authors":"Saranjeet Kaur, Akash Deb","doi":"10.2174/0118722083312186240822051057","DOIUrl":"https://doi.org/10.2174/0118722083312186240822051057","url":null,"abstract":"<p><strong>Background: </strong>In nature, orchid plants are obligate myco-heterotrophs, and rely on mycorrhizal nutrient resources to grow and sustain in the wild, until they become physiologically active photosynthetic plants. Their seeds lack nutrient reserves and receive the necessary carbon from symbiotic fungi during germination. A mycorrhizal fungus provides nutrients, especially sugars, as well as water to the corresponding host plant. The range and distribution of orchid mycorrhizal fungi influence the survivability of orchid populations in their natural habitats. Mycorrhizae form symbiotic connections with the parenchymatous tissues of the roots of orchid plants.</p><p><strong>Objective: </strong>The objective of this study was to examine the presence of mycorrhiza in the roots of Aerides multiflora during the vegetative phase Methods: Fresh roots were hand-sectioned, and thin sections were observed under the microscope to locate the presence of mycorrhiza. Simultaneously, to observe the expansion of mycorrhiza in the cortical region.</p><p><strong>Results: </strong>During the vegetative phase of plant growth, a peloton-like structure forms within the cortical region of the orchid roots. Mycorrhizae was observed to be distributed throughout the cortical layer of the root.</p><p><strong>Conclusion: </strong>This communication reviews the role of mycorrhiza in orchid plants.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploration of Developmental Variants of Predatory Ladybird, Coccinella septumpunctata L. (Coleoptera: Coccinellidae) on an Artificial Diet. 捕食性瓢虫 Coccinella septumpunctata L.(鞘翅目:瓢虫科)在人工食物上的发育变异探索
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-08-21 DOI: 10.2174/0118722083313758240813102715
Arshi Siddiqui, Shaizee, Danish Khan

Introduction: This study aimed to focus on the identification, rearing, and exploration of developmental variants of the predatory ladybird, Coccinella septempunctata L., renowned for its efficacy as a biological control agent and its predation on agricultural pests. However, comprehensive knowledge concerning the occurrence and characteristics of developmental variants in this species remains limited.

Method: In this study, through meticulous monitoring and exploration, we identified developmental variants exhibiting distinct sexual attributes, as well as survival rates.

Result: The research outcomes enhance our understanding of the developmental variations within an egg batch of C. septempunctata.

Conclusion: Moreover, the findings hold practical implications for the implementation of biological control strategies in agriculture, as specific variants may possess unique characteristics that enhance their effectiveness as natural enemies against pests.

导言:该研究的目的是鉴定、饲养和探索捕食性瓢虫七星瓢虫的发育变体。然而,有关该物种发育变体的发生和特征的全面知识仍然有限:方法:在本研究中,通过细致的监测和探索,我们确定了表现出不同性状的发育变体以及存活率:结果:研究成果加深了我们对七鳃鳗一批卵内发育变异的了解:此外,研究结果对在农业中实施生物防治战略具有实际意义,因为特定变体可能具有独特的特征,能提高其作为天敌对付害虫的效果。
{"title":"Exploration of Developmental Variants of Predatory Ladybird, Coccinella septumpunctata L. (Coleoptera: Coccinellidae) on an Artificial Diet.","authors":"Arshi Siddiqui, Shaizee, Danish Khan","doi":"10.2174/0118722083313758240813102715","DOIUrl":"https://doi.org/10.2174/0118722083313758240813102715","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to focus on the identification, rearing, and exploration of developmental variants of the predatory ladybird, Coccinella septempunctata L., renowned for its efficacy as a biological control agent and its predation on agricultural pests. However, comprehensive knowledge concerning the occurrence and characteristics of developmental variants in this species remains limited.</p><p><strong>Method: </strong>In this study, through meticulous monitoring and exploration, we identified developmental variants exhibiting distinct sexual attributes, as well as survival rates.</p><p><strong>Result: </strong>The research outcomes enhance our understanding of the developmental variations within an egg batch of C. septempunctata.</p><p><strong>Conclusion: </strong>Moreover, the findings hold practical implications for the implementation of biological control strategies in agriculture, as specific variants may possess unique characteristics that enhance their effectiveness as natural enemies against pests.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling Anthraquinones: Diverse Health Benefits of an Essential Secondary Metabolite. 揭开蒽醌的神秘面纱:重要次级代谢物的多种健康益处。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-07-04 DOI: 10.2174/0118722083301761240628083511
Mushfa Khatoon, Amita Dubey, Janhvi Km Verma

Since ancient times, plants have been used as a remedy for numerous diseases. The pharmacological properties of plants are due to the presence of secondary metabolites like terpenoids, flavonoids, alkaloids, etc. Anthraquinones represent a group of naturally occurring quinones found generously across various plant species. Anthraquinones attract a significant amount of attention due to their reported efficacy in treating a wide range of diseases. Their complex chemical structures, combined with inherent medicinal properties, underscore their potential as agents for therapy. They demonstrate several therapeutic properties such as laxative, antitumor, antimalarial, antibacterial, antifungal, antioxidant, etc. Anthraquinones are found in different forms (derivatives) in plants, and they exhibit various medicinal properties due to their structure and chemical nature. The precursors for the biosynthesis of anthraquinones in higher plants are provided by different pathways such as plastidic hemiterpenoid 2-C-methyl-D-erthriol4-phosphate (MEP), mevalonate (MVA), isochorismate synthase and polyketide. By conducting a thorough analysis of scientific literature, this review provides insights into the intricate interplay between anthraquinone biosynthesis and its broad-ranging contributions to human health.

自古以来,植物就被用来治疗多种疾病。植物的药理特性得益于萜类、黄酮类、生物碱等次生代谢物的存在。蒽醌是一组天然存在的醌类化合物,广泛存在于各种植物物种中。据报道,蒽醌类化合物具有治疗多种疾病的功效,因此备受关注。蒽醌类化合物的化学结构复杂,加上其固有的药用特性,凸显了它们作为治疗药物的潜力。它们具有多种治疗特性,如润肠通便、抗肿瘤、抗疟、抗菌、抗真菌、抗氧化等。蒽醌类化合物以不同的形式(衍生物)存在于植物中,由于其结构和化学性质,它们具有多种药用特性。在高等植物中,蒽醌类化合物的生物合成前体由不同途径提供,如质体半萜 2-C-甲基-D-赤藓醇-4-磷酸酯(MEP)、甲羟戊酸(MVA)、异橙皮苷酸合成酶和多酮类化合物。通过对科学文献进行深入分析,本综述深入探讨了蒽醌生物合成之间错综复杂的相互作用及其对人类健康的广泛贡献。
{"title":"Unveiling Anthraquinones: Diverse Health Benefits of an Essential Secondary Metabolite.","authors":"Mushfa Khatoon, Amita Dubey, Janhvi Km Verma","doi":"10.2174/0118722083301761240628083511","DOIUrl":"https://doi.org/10.2174/0118722083301761240628083511","url":null,"abstract":"<p><p>Since ancient times, plants have been used as a remedy for numerous diseases. The pharmacological properties of plants are due to the presence of secondary metabolites like terpenoids, flavonoids, alkaloids, etc. Anthraquinones represent a group of naturally occurring quinones found generously across various plant species. Anthraquinones attract a significant amount of attention due to their reported efficacy in treating a wide range of diseases. Their complex chemical structures, combined with inherent medicinal properties, underscore their potential as agents for therapy. They demonstrate several therapeutic properties such as laxative, antitumor, antimalarial, antibacterial, antifungal, antioxidant, etc. Anthraquinones are found in different forms (derivatives) in plants, and they exhibit various medicinal properties due to their structure and chemical nature. The precursors for the biosynthesis of anthraquinones in higher plants are provided by different pathways such as plastidic hemiterpenoid 2-C-methyl-D-erthriol4-phosphate (MEP), mevalonate (MVA), isochorismate synthase and polyketide. By conducting a thorough analysis of scientific literature, this review provides insights into the intricate interplay between anthraquinone biosynthesis and its broad-ranging contributions to human health.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging Methods in the Identification of Bacterial Respiratory Tract Pathogens. 鉴定呼吸道细菌病原体的新方法。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-07-04 DOI: 10.2174/0118722083309510240625085931
Flora Kiaghobadi, Ali Dehshahri, Younes Ghasemi, Mohammad Hossein Morowvat

Aims: Here, we will review different bacterial causes of respiratory tract infections and discuss the available diagnostic methods. Moreover, we will provide some recently published patents and newer techniques, such as respiratory panels and omics approaches, and express the challenges in this path.

Background: Respiratory tract infections (RTIs) include those infections that can lead to the involvement of different respiratory parts, including the sinuses, throat, airways, and lungs. Acute respiratory tract infection is the leading cause of death from infectious illnesses worldwide. According to the World Health Organization, 1.6 to 2.2 million deaths have occurred due to acute respiratory infections in children under five years of age. About 4 million people die annually from respiratory infections, 98% of which are caused by lower respiratory infections.

Results: Depending on the type of pathogen, the severity of the infection can vary from mild to severe and even cause death. The most important pathogens involved in respiratory tract infections include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The symptoms are often similar, but the treatment can vary greatly. Therefore, correct diagnosis is so important. There are several methods for diagnosing respiratory infections. Traditional tests include the culture of respiratory samples, considered the primary tool for diagnosing respiratory infections in laboratories, and less common standard tests include rapid and antigenic tests. It is essential to think that the culture method is reliable. In the original method of diagnosing respiratory infections, some bacteria were challenging to grow successfully, and many clinical laboratories needed to be equipped for viral cultures. Another issue is the time to get the results, which may take up to 7 days. Rapid and antigenic tests are faster but need to be more accurate.

Conclusion: The clinical laboratories are trying to be equipped with molecular methods for detecting respiratory pathogens and identifying the genetic material of the infectious agent in these new methods as the primary method in their agenda.

目的:在此,我们将回顾导致呼吸道感染的不同细菌病因,并讨论现有的诊断方法。此外,我们还将提供一些最新发表的专利和较新的技术,如呼吸系统面板和 omics 方法,并阐述这一领域所面临的挑战:背景:呼吸道感染(RTIs)包括可导致不同呼吸道部位受累的感染,包括鼻窦、咽喉、呼吸道和肺部。急性呼吸道感染是全球传染病致死的主要原因。据世界卫生组织统计,五岁以下儿童因急性呼吸道感染死亡的人数达 160 万至 220 万。每年约有 400 万人死于呼吸道感染,其中 98% 由下呼吸道感染引起:根据病原体的种类,感染的严重程度可从轻微到严重不等,甚至会导致死亡。呼吸道感染最主要的病原体包括肺炎链球菌、流感嗜血杆菌和白喉摩拉菌。症状通常相似,但治疗方法却大相径庭。因此,正确诊断非常重要。诊断呼吸道感染有多种方法。传统的检测方法包括呼吸道样本培养,这被认为是实验室诊断呼吸道感染的主要工具,而不太常见的标准检测方法包括快速检测和抗原检测。必须认为培养方法是可靠的。在最初的呼吸道感染诊断方法中,一些细菌的成功培养具有挑战性,许多临床实验室需要配备病毒培养设备。另一个问题是得到结果的时间,可能需要长达 7 天的时间。快速和抗原检测更快,但需要更准确:结论:临床实验室正试图配备检测呼吸道病原体的分子方法,并将这些新方法作为主要方法来鉴定传染源的遗传物质。
{"title":"Emerging Methods in the Identification of Bacterial Respiratory Tract Pathogens.","authors":"Flora Kiaghobadi, Ali Dehshahri, Younes Ghasemi, Mohammad Hossein Morowvat","doi":"10.2174/0118722083309510240625085931","DOIUrl":"https://doi.org/10.2174/0118722083309510240625085931","url":null,"abstract":"<p><strong>Aims: </strong>Here, we will review different bacterial causes of respiratory tract infections and discuss the available diagnostic methods. Moreover, we will provide some recently published patents and newer techniques, such as respiratory panels and omics approaches, and express the challenges in this path.</p><p><strong>Background: </strong>Respiratory tract infections (RTIs) include those infections that can lead to the involvement of different respiratory parts, including the sinuses, throat, airways, and lungs. Acute respiratory tract infection is the leading cause of death from infectious illnesses worldwide. According to the World Health Organization, 1.6 to 2.2 million deaths have occurred due to acute respiratory infections in children under five years of age. About 4 million people die annually from respiratory infections, 98% of which are caused by lower respiratory infections.</p><p><strong>Results: </strong>Depending on the type of pathogen, the severity of the infection can vary from mild to severe and even cause death. The most important pathogens involved in respiratory tract infections include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The symptoms are often similar, but the treatment can vary greatly. Therefore, correct diagnosis is so important. There are several methods for diagnosing respiratory infections. Traditional tests include the culture of respiratory samples, considered the primary tool for diagnosing respiratory infections in laboratories, and less common standard tests include rapid and antigenic tests. It is essential to think that the culture method is reliable. In the original method of diagnosing respiratory infections, some bacteria were challenging to grow successfully, and many clinical laboratories needed to be equipped for viral cultures. Another issue is the time to get the results, which may take up to 7 days. Rapid and antigenic tests are faster but need to be more accurate.</p><p><strong>Conclusion: </strong>The clinical laboratories are trying to be equipped with molecular methods for detecting respiratory pathogens and identifying the genetic material of the infectious agent in these new methods as the primary method in their agenda.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Acharas Sapota Linn in Traditional Medicine. Acharas Sapota Linn 在传统医学中的应用。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-06-24 DOI: 10.2174/0118722083304962240619101244
Ajay Ramdas Nannar

This article offers a thorough analysis of the contemporary application of Achras Sapota Linn, or sapodilla, in conventional medicine. Tropical fruit-bearing Achras Sapota Linn has long been used in many traditional medical systems. The study examines Achras Sapota Linn's phytochemical makeup and pharmacological characteristics with an emphasis on the plant's possible medical uses in the treatment of a range of illnesses. Moreover, it highlights the safety and efficacy characteristics of Achras Sapota Linn and talks about new research and clinical trials that back up its traditional applications. This study also discusses obstacles and potential avenues for further research and application of Achras Sapota Linn in contemporary medicine. All things considered, it emphasizes how important Achras Sapota Linn is to traditional medicine as a therapeutic resource.

本文深入分析了Achras Sapota Linn(又称皂荚)在传统医学中的当代应用。热带水果 Achras Sapota Linn 长期以来一直被用于许多传统医学体系中。本研究探讨了 Achras Sapota Linn 的植物化学成分和药理特性,重点是该植物在治疗一系列疾病方面的可能医疗用途。此外,研究还强调了 Achras Sapota Linn 的安全性和有效性,并介绍了支持其传统应用的新研究和临床试验。本研究还讨论了进一步研究 Achras Sapota Linn 并将其应用于现代医学的障碍和潜在途径。综上所述,本研究强调了 Achras Sapota Linn 作为一种治疗资源对传统医学的重要性。
{"title":"Application of Acharas Sapota Linn in Traditional Medicine.","authors":"Ajay Ramdas Nannar","doi":"10.2174/0118722083304962240619101244","DOIUrl":"https://doi.org/10.2174/0118722083304962240619101244","url":null,"abstract":"<p><p>This article offers a thorough analysis of the contemporary application of Achras Sapota Linn, or sapodilla, in conventional medicine. Tropical fruit-bearing Achras Sapota Linn has long been used in many traditional medical systems. The study examines Achras Sapota Linn's phytochemical makeup and pharmacological characteristics with an emphasis on the plant's possible medical uses in the treatment of a range of illnesses. Moreover, it highlights the safety and efficacy characteristics of Achras Sapota Linn and talks about new research and clinical trials that back up its traditional applications. This study also discusses obstacles and potential avenues for further research and application of Achras Sapota Linn in contemporary medicine. All things considered, it emphasizes how important Achras Sapota Linn is to traditional medicine as a therapeutic resource.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141451394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open Innovation or Traditional Patenting Strategies to Efficiently Address Health Emergencies? How Patent Information Was Used Towards Effective Treatments for COVID-19. 采用开放式创新还是传统专利战略来有效解决突发卫生事件?如何利用专利信息有效治疗 COVID-19。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-06-19 DOI: 10.2174/0118722083303431240528041945
Tatiana Duque Martins Ertner de Almeida, Diéricon Sousa Cordeiro

Introduction/objective: During the 1150 days of COVID-19 pandemic there were great efforts to develop efficient treatments for the disease. After this long time, some drugs emerged as treatment for COVID-19. Some of them are new drugs, most of them, known drugs. These developments were triggered by information already available in patent documents. Pharmaceutical companies, therefore, rushed to conduct drugs evaluations and trials in order to deliver to the world a reasonable treatment that could reach the majority of its population. However, it is not immediately clear how companies operated to reach their goals. The ability of open innovation to achieve results assertively and faster than closed innovation strategies is questioned and therefore, it is questioned whether pharmaceutical companies use open innovation to face COVID-19.

Methods: In this work, data available on patent databases were mined to inform about the scientific and technological panorama of selected drugs tested for COVID-19 treatment and to understand the perspectives of such developments during the pandemic.

Results: This study evidenced that most treatments were based on known drugs, that some of the initially promising drugs were abandoned during the pandemic, and that it was able to inform if open innovation and collaborations were explored strategies.

Conclusion: This study evidenced that the developments during COVID-19 were not based on open innovation by revealing a patent race towards the treatment development, but with practically no collaborations or information exchange between companies, universities, and research facilities.

导言/目标:在 COVID-19 大流行的 1150 天里,人们一直在努力开发该疾病的有效治疗方法。经过这么长时间的努力,出现了一些治疗 COVID-19 的药物。其中一些是新药,大多数是已知药物。这些药物的研发是由专利文件中已有的信息引发的。因此,制药公司急忙进行药物评估和试验,以便向全世界提供一种能够惠及大多数人的合理治疗方法。然而,人们并不清楚公司是如何运作以实现其目标的。与封闭式创新战略相比,开放式创新能否自信而快速地取得成果受到质疑,因此,制药公司是否利用开放式创新来面对 COVID-19 也受到质疑:在这项工作中,对专利数据库中的数据进行了挖掘,以了解用于 COVID-19 治疗的选定试验药物的科技全景,并了解在大流行期间此类发展的前景:结果:这项研究表明,大多数治疗方法都是基于已知药物,一些最初很有前景的药物在大流行期间被放弃了,而且它还能说明开放式创新和合作是否是探索的战略:这项研究表明,COVID-19 期间的发展并非基于开放式创新,它揭示了治疗方法开发中的专利竞赛,但公司、大学和研究机构之间几乎没有合作或信息交流。
{"title":"Open Innovation or Traditional Patenting Strategies to Efficiently Address Health Emergencies? How Patent Information Was Used Towards Effective Treatments for COVID-19.","authors":"Tatiana Duque Martins Ertner de Almeida, Diéricon Sousa Cordeiro","doi":"10.2174/0118722083303431240528041945","DOIUrl":"https://doi.org/10.2174/0118722083303431240528041945","url":null,"abstract":"<p><strong>Introduction/objective: </strong>During the 1150 days of COVID-19 pandemic there were great efforts to develop efficient treatments for the disease. After this long time, some drugs emerged as treatment for COVID-19. Some of them are new drugs, most of them, known drugs. These developments were triggered by information already available in patent documents. Pharmaceutical companies, therefore, rushed to conduct drugs evaluations and trials in order to deliver to the world a reasonable treatment that could reach the majority of its population. However, it is not immediately clear how companies operated to reach their goals. The ability of open innovation to achieve results assertively and faster than closed innovation strategies is questioned and therefore, it is questioned whether pharmaceutical companies use open innovation to face COVID-19.</p><p><strong>Methods: </strong>In this work, data available on patent databases were mined to inform about the scientific and technological panorama of selected drugs tested for COVID-19 treatment and to understand the perspectives of such developments during the pandemic.</p><p><strong>Results: </strong>This study evidenced that most treatments were based on known drugs, that some of the initially promising drugs were abandoned during the pandemic, and that it was able to inform if open innovation and collaborations were explored strategies.</p><p><strong>Conclusion: </strong>This study evidenced that the developments during COVID-19 were not based on open innovation by revealing a patent race towards the treatment development, but with practically no collaborations or information exchange between companies, universities, and research facilities.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actinobacteria: Smart Micro-Factories for The Health Sector. 放线菌:健康领域的智能微型工厂。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-05-10 DOI: 10.2174/0118722083300181240429072502
Roohi Roohi, Naushin Bano

Antibiotics are considered "wonder drugs" due to the fact that they are the most extensively utilised medication in the world. They are used to cure a broad spectrum of diseases and lethal infections. A variety of bacteria and fungi produce antibiotics as a result of secondary metabolism; however, their production is dominated by a special class of bacteria, namely Actinobacteria. Actinobacteria are gram-positive bacteria with high G+C content and unparalleled antibiotic-producing ability. They produce numerous polyenes, tetracyclines, β-lactams, macrolides, and peptides. Actinobacteria are ubiquitous in nature and are isolated from various sources, such as marine and terrestrial endophytes of plants and air. They are studied for their relative antibiotic-producing ability along with the mechanism that the antibiotics follow to annihilate the pathogenic agents that include bacteria, fungi, protozoans, helminths, etc. Actinobacteria isolated from endophytes of medicinal plants have amassed significant attention as they interfere with the metabolism of medicinal plants and acquire enormous benefits from it in the form of conspicuous novel antibiotic-producing ability. Actinobacteria is not only an antibiotic but also a rich source of anticancer compounds that are widely used owing to its remarkable tumorigenic potential. Today, amongst Actinobacteria, class Streptomyces subjugates the area of antibiotic production, producing 70% of all known antibiotics. The uniqueness of bioactive Actinobacteria has turned the attention of scientists worldwide in order to explore its potentiality as effective "micronanofactories". This study provides a brief overview of the production of antibiotics from Actinobacteria inhabiting diverse environments and the methods involved in the screening of antibiotics.

抗生素被誉为 "神奇药物",因为它们是世界上使用最广泛的药物。它们被用于治疗多种疾病和致命感染。多种细菌和真菌通过次级代谢产生抗生素,但生产抗生素的主要是一类特殊的细菌,即放线菌。放线菌是革兰氏阳性细菌,具有很高的 G+C 含量和无与伦比的抗生素生产能力。它们产生大量多烯类、四环素类、β-内酰胺类、大环内酯类和肽类抗生素。放线菌在自然界中无处不在,可从各种来源(如海洋和陆地植物的内生菌和空气)分离出来。人们研究它们产生抗生素的能力以及抗生素消灭细菌、真菌、原生动物、蠕虫等病原体的机制。从药用植物内生菌中分离出的放线菌引起了人们的极大关注,因为它们干扰了药用植物的新陈代谢,并从中获得了巨大的利益,具有明显的新型抗生素生产能力。放线菌不仅是一种抗生素,也是抗癌化合物的丰富来源,由于其显著的抗肿瘤潜力而被广泛使用。如今,在放线菌中,链霉菌类是抗生素生产领域的霸主,其生产的抗生素占所有已知抗生素的 70%。具有生物活性的放线菌的独特性吸引了全世界科学家的关注,以探索其作为有效 "微型工厂 "的潜力。本研究简要概述了栖息在不同环境中的放线菌生产抗生素的情况以及筛选抗生素的方法。
{"title":"Actinobacteria: Smart Micro-Factories for The Health Sector.","authors":"Roohi Roohi, Naushin Bano","doi":"10.2174/0118722083300181240429072502","DOIUrl":"https://doi.org/10.2174/0118722083300181240429072502","url":null,"abstract":"<p><p>Antibiotics are considered \"wonder drugs\" due to the fact that they are the most extensively utilised medication in the world. They are used to cure a broad spectrum of diseases and lethal infections. A variety of bacteria and fungi produce antibiotics as a result of secondary metabolism; however, their production is dominated by a special class of bacteria, namely Actinobacteria. Actinobacteria are gram-positive bacteria with high G+C content and unparalleled antibiotic-producing ability. They produce numerous polyenes, tetracyclines, β-lactams, macrolides, and peptides. Actinobacteria are ubiquitous in nature and are isolated from various sources, such as marine and terrestrial endophytes of plants and air. They are studied for their relative antibiotic-producing ability along with the mechanism that the antibiotics follow to annihilate the pathogenic agents that include bacteria, fungi, protozoans, helminths, etc. Actinobacteria isolated from endophytes of medicinal plants have amassed significant attention as they interfere with the metabolism of medicinal plants and acquire enormous benefits from it in the form of conspicuous novel antibiotic-producing ability. Actinobacteria is not only an antibiotic but also a rich source of anticancer compounds that are widely used owing to its remarkable tumorigenic potential. Today, amongst Actinobacteria, class Streptomyces subjugates the area of antibiotic production, producing 70% of all known antibiotics. The uniqueness of bioactive Actinobacteria has turned the attention of scientists worldwide in order to explore its potentiality as effective \"micronanofactories\". This study provides a brief overview of the production of antibiotics from Actinobacteria inhabiting diverse environments and the methods involved in the screening of antibiotics.</p>","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140958030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospects of Plant Derived Bioactive Compounds as Nanoparticles for Biotechnological Applications. 将植物提取的生物活性化合物作为纳米颗粒用于生物技术应用的前景。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-19 DOI: 10.2174/0118722083301253240417114400
N. Bano, Syed Khalida Izhar, Anamika Gupta, M. Zaheer, Roohi
Nanoparticles bestow beneficial impacts on plants, specifically in increasing photosynthetic capacity and germination rate, pesticide delivery, managing pathogenicity and enhancing nutrient supply. The nanoparticles produced from the medicinal plant extracts are identified as an exceptional applicant in nanomedicine, cosmetics, and agriculture for the treatment of diseases as antimicrobial, antioxidant and anticancer agents, etc. Plant extracts actually have bioactive metabolites that provide therapeutic potential against a variety of diseases. Herein, we review the production of bioactive compounds from leaves, roots, seeds, flowers and stems. We further summarize the different methods for obtaining plant extracts and the green technologies for the synthesis of nanoparticles of plant derived bioactive compounds. Biotechnological aspects of these synthesized nanoparticles are also added here as highlights of this review. Overall, plant derived nanoparticles provide an alternative to conventional approaches for drug delivery as well and present exciting opportunities for future research on novel areas.
纳米粒子对植物有益,特别是在提高光合作用能力和发芽率、农药输送、控制病原性和增强营养供应方面。从药用植物提取物中生产的纳米粒子被认为是纳米医学、化妆品和农业中治疗疾病的抗菌剂、抗氧化剂和抗癌剂等的理想应用。植物提取物实际上具有生物活性代谢物,可对多种疾病提供治疗潜力。在此,我们回顾了从叶、根、种子、花和茎中提取生物活性化合物的过程。我们进一步总结了获取植物提取物的不同方法,以及合成植物衍生生物活性化合物纳米颗粒的绿色技术。作为本综述的亮点,我们还补充了这些合成纳米粒子的生物技术方面。总之,植物衍生纳米粒子为传统的给药方法提供了一种替代方案,并为未来新领域的研究提供了令人兴奋的机会。
{"title":"Prospects of Plant Derived Bioactive Compounds as Nanoparticles for Biotechnological Applications.","authors":"N. Bano, Syed Khalida Izhar, Anamika Gupta, M. Zaheer, Roohi","doi":"10.2174/0118722083301253240417114400","DOIUrl":"https://doi.org/10.2174/0118722083301253240417114400","url":null,"abstract":"Nanoparticles bestow beneficial impacts on plants, specifically in increasing photosynthetic capacity and germination rate, pesticide delivery, managing pathogenicity and enhancing nutrient supply. The nanoparticles produced from the medicinal plant extracts are identified as an exceptional applicant in nanomedicine, cosmetics, and agriculture for the treatment of diseases as antimicrobial, antioxidant and anticancer agents, etc. Plant extracts actually have bioactive metabolites that provide therapeutic potential against a variety of diseases. Herein, we review the production of bioactive compounds from leaves, roots, seeds, flowers and stems. We further summarize the different methods for obtaining plant extracts and the green technologies for the synthesis of nanoparticles of plant derived bioactive compounds. Biotechnological aspects of these synthesized nanoparticles are also added here as highlights of this review. Overall, plant derived nanoparticles provide an alternative to conventional approaches for drug delivery as well and present exciting opportunities for future research on novel areas.","PeriodicalId":21064,"journal":{"name":"Recent patents on biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140682560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Recent patents on biotechnology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1